216 related articles for article (PubMed ID: 9430796)
21. Corticotropin-releasing factor type 1 receptors mediate the visceral hyperalgesia induced by repeated psychological stress in rats.
Larauche M; Bradesi S; Million M; McLean P; Taché Y; Mayer EA; McRoberts JA
Am J Physiol Gastrointest Liver Physiol; 2008 Apr; 294(4):G1033-40. PubMed ID: 18308857
[TBL] [Abstract][Full Text] [Related]
22. GPER-mediated, oestrogen-dependent visceral hypersensitivity in stressed rats is associated with mast cell tryptase and histamine expression.
Xu S; Wang X; Zhao J; Yang S; Dong L; Qin B
Fundam Clin Pharmacol; 2020 Aug; 34(4):433-443. PubMed ID: 31967341
[TBL] [Abstract][Full Text] [Related]
23. ICV administration of CRF blocker (CRF9-41 delta helical) reduces morphine withdrawal in rats.
Brugger S; Sánchez R; Brugger AJ; Martinez JA
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Jul; 22(5):775-85. PubMed ID: 9723119
[TBL] [Abstract][Full Text] [Related]
24. Effects of prenatal stress on defensive withdrawal behavior and corticotropin releasing factor systems in rat brain.
Ward HE; Johnson EA; Salm AK; Birkle DL
Physiol Behav; 2000; 70(3-4):359-66. PubMed ID: 11006435
[TBL] [Abstract][Full Text] [Related]
25. Corticotropin-releasing factor modulates dietary preference in nutritionally and physically stressed rats.
Heinrichs SC; Koob GF
Psychopharmacology (Berl); 1992; 109(1-2):177-84. PubMed ID: 1365653
[TBL] [Abstract][Full Text] [Related]
26. Alpha-helical CRF(9-41) prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats.
Kask A; Rägo L; Harro J
Neuroreport; 1997 Nov; 8(16):3645-7. PubMed ID: 9427342
[TBL] [Abstract][Full Text] [Related]
27. Behavioral effects of central administration of the novel CRF antagonist astressin in rats.
Spina MG; Basso AM; Zorrilla EP; Heyser CJ; Rivier J; Vale W; Merlo-Pich E; Koob GF
Neuropsychopharmacology; 2000 Mar; 22(3):230-9. PubMed ID: 10693150
[TBL] [Abstract][Full Text] [Related]
28. Chronic low-level administration of diquat increases the nociceptive response to gastric distension in rats: role of mast cells and tachykinin receptor activation.
Anton PM; Theodorou V; Fioramonti J; Bueno L
Pain; 2001 May; 92(1-2):219-27. PubMed ID: 11323143
[TBL] [Abstract][Full Text] [Related]
29. Corticotropin-releasing factor antagonist reduces emotionality in socially defeated rats via direct neurotropic action.
Heinrichs SC; Pich EM; Miczek KA; Britton KT; Koob GF
Brain Res; 1992 May; 581(2):190-7. PubMed ID: 1327398
[TBL] [Abstract][Full Text] [Related]
30. Differential antagonist activity of alpha-helical corticotropin-releasing factor9-41 in three bioassay systems.
Fisher L; Rivier C; Rivier J; Brown M
Endocrinology; 1991 Sep; 129(3):1312-6. PubMed ID: 1651845
[TBL] [Abstract][Full Text] [Related]
31. Stress-induced enhancement of colitis in rats: CRF and arginine vasopressin are not involved.
Gué M; Bonbonne C; Fioramonti J; Moré J; Del Rio-Lachèze C; Coméra C; Buéno L
Am J Physiol; 1997 Jan; 272(1 Pt 1):G84-91. PubMed ID: 9038880
[TBL] [Abstract][Full Text] [Related]
32. Permissive role of corticotropin-releasing factor in the acute stress-induced prolactin release in female rats.
Akema T; Chiba A; Oshida M; Kimura F; Toyoda J
Neurosci Lett; 1995 Sep; 198(2):146-8. PubMed ID: 8592642
[TBL] [Abstract][Full Text] [Related]
33. CRF1 receptors as a therapeutic target for irritable bowel syndrome.
Martinez V; Taché Y
Curr Pharm Des; 2006; 12(31):4071-88. PubMed ID: 17100612
[TBL] [Abstract][Full Text] [Related]
34. Restraint changes pentobarbital-induced sleeping time in rats: evidence that arousal is modulated by brain corticotropin-releasing hormone and opioid in stress.
Shibasaki T; Imaki T; Hotta M; Ling N; Demura H
Regul Pept; 1994 May; 51(2):141-9. PubMed ID: 8059010
[TBL] [Abstract][Full Text] [Related]
35. Involvement of neurokinin 1 and 2 receptors in viscerosensitive response to rectal distension in rats.
Julia V; Morteau O; Buéno L
Gastroenterology; 1994 Jul; 107(1):94-102. PubMed ID: 7517374
[TBL] [Abstract][Full Text] [Related]
36. Reduction of exploratory behavior by intraperitoneal injection of interleukin-1 involves brain corticotropin-releasing factor.
Dunn AJ; Antoon M; Chapman Y
Brain Res Bull; 1991 Apr; 26(4):539-42. PubMed ID: 1868353
[TBL] [Abstract][Full Text] [Related]
37. Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats.
Shaham Y; Funk D; Erb S; Brown TJ; Walker CD; Stewart J
J Neurosci; 1997 Apr; 17(7):2605-14. PubMed ID: 9065520
[TBL] [Abstract][Full Text] [Related]
38. Regulation of duodenal bicarbonate secretion during stress by corticotropin-releasing factor and beta-endorphin.
Lenz HJ
Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1417-20. PubMed ID: 2521953
[TBL] [Abstract][Full Text] [Related]
39. Treatment with alpha-helical-CRF(9-41) prevents the anorectic effect of 17-beta-estradiol.
Dagnault A; Ouerghi D; Richard D
Brain Res Bull; 1993; 32(6):689-92. PubMed ID: 8221168
[TBL] [Abstract][Full Text] [Related]
40. Corticotropin-releasing hormone mimics stress-induced colonic epithelial pathophysiology in the rat.
Santos J; Saunders PR; Hanssen NP; Yang PC; Yates D; Groot JA; Perdue MH
Am J Physiol; 1999 Aug; 277(2):G391-9. PubMed ID: 10444454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
